🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT05268523
Recruiting Not applicable

Self-Management Interventions for Long COVID-19

NCT05268523 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2021-11-23
Last updated
2024-11-25

Condition(s) studied

COVID-19

Investigational drug(s) / intervention(s)

Education and Strategies InterventionMindfulness Skills Intervention

Education and Strategies Intervention: Sessions will be led by registered therapists and clinicians in the fields of psychology, rheumatology, cardiology and neurology. The sessions will be comprised of educational presentations on the nature of persisting symptoms after COVID-19 and associated recommendations for self-management.

Mindfulness Skills Intervention: The Mindfulness Skills Intervention is an 8-week program designed to provide an introduction to some basic mindfulness skills. Each session begins with a brief breath focus practice followed by discussion of the experience and sharing/discussion of the previous week including participants' experiences. Each session also includes some didactics, and a new, related mindfulness skill is introduced and practiced, followed by another discussion.

Study summary

The purpose of this study is to investigate and compare the feasibility and efficacy of two group-based interventions (education vs. mindfulness) to help self-manage Long-COVID symptoms.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Clinically diagnosed Long-COVID plus PCR positivity with and without hospitalization * 3-12 months post-diagnosis of COVID-19 * \>2 self-reported persisting symptoms in \>1 mood, cognitive and/or somatic symptom domain * Age \>18 * English speaking * Private access to computer/internet Exclusion Criteria: * Acute ventilator support * Diagnosed dementia * Past/present history of psychotic illness or mania and, because of potential overlap in symptoms, diagnosis of chronic fatigue syndrome, fibromyalgia, chronic lyme disease or traumatic brain injury * Long-COVID symptom severity (i.e., physical, cognitive, emotional symptoms) at a level that would significantly interfere with attendance/adherence to the intervention protocol

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Toronto Rehabilitation Institute Toronto Ontario Recruiting

More Toronto Rehabilitation Institute trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05268523 on ClinicalTrials.gov ↗ ← All trials in Canada